Showing results (631-640 of 993) with videos related to
Sort By:
Pageof 100
Biochemical Pharmacology|July 19, 1994
Reversal of P-glycoprotein-mediated multidrug resistance by pure anti-oestrogens and novel tamoxifen derivativesJ Kirk, S K Syed, A L Harris, et al.Journal of Clinical Pathology|January 1, 1994
Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid originJ Dixon, L Kaklamanis, H Turley, et al.Cancer Research|November 3, 2001
Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancerA Giatromanolaki, M I Koukourakis, E Sivridis, et al.Histology and Histopathology|September 2, 2005
DEC1 expression in 1p-aberrant oligodendroglial neoplasmsM Preusser, P Birner, I M Ambros, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell linesA Jones, C Fujiyama, C Blanche, et al.Journal of the National Cancer Institute|February 1, 1995
Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cellsH T Zhang, P Craft, P A Scott, et al.Journal of Clinical Pathology|January 29, 2005
LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancerM I Koukourakis, A Giatromanolaki, E Sivridis, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscleA L Harris, B M Lemp, R G Bentley, et al.British Journal of Cancer|November 1, 1995
Importance of P450 reductase activity in determining sensitivity of breast tumour cells to the bioreductive drug, tirapazamine (SR 4233)A V Patterson, H M Barham, E C Chinje, et al.The American Journal of Pathology|January 1, 1993
p53 expression in colorectal adenomasL Kaklamanis, K C Gatter, N Mortensen, et al.Pageof 100